{"id":7499,"date":"2018-12-20T13:25:34","date_gmt":"2018-12-20T12:25:34","guid":{"rendered":"http:\/\/wordpress.p545550.webspaceconfig.de\/uncategorized\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\/"},"modified":"2020-07-03T09:37:17","modified_gmt":"2020-07-03T07:37:17","slug":"adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin","status":"publish","type":"post","link":"https:\/\/www.izb-online.de\/en\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\/","title":{"rendered":"adivo develops new drugs for veterinary medicine"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row el_class=&#8221;gco-magazine-container&#8221;][vc_column el_class=&#8221;bildspalte&#8221;][vc_row_inner][vc_column_inner offset=&#8221;vc_col-lg-12 vc_col-md-12&#8243;][vc_column_text el_class=&#8221;gco-magazine&#8211;title&#8221;]<\/p>\n<h1>adivo develops new drugs for veterinary medicine<\/h1>\n<p>[\/vc_column_text][vc_column_text el_class=&#8221;gco-magazine-lead&#8221;]The spin-out of MorphoSys focuses on innovative antibody therapy[\/vc_column_text][vc_column_text el_class=&#8221;gco-magazine&#8211;post-date&#8221;]December 2018[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_single_image image=&#8221;7497&#8243; img_size=&#8221;full&#8221;][vc_column_text el_class=&#8221;gco-magazine-copyright&#8221;]\u00a9 adivo GmbH[\/vc_column_text][vc_column_text el_class=&#8221;gco-magazine-picture-discription&#8221;]Dr. Kathrin Ladetzki-\u00adBaehs, Dr. Markus Waldhuber, Managing Directors, \u00adadivo GmbH[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=&#8221;gco-magazine-container&#8211;copy&#8221;][vc_column_inner][vc_column_text]The biotech start-up adivo has set itself the goal of meeting the high demand for novel drugs for the treatment of cancer and chronic inflammatory diseases in dogs, with the potential to expand these activities to other animal species in the future. adivo GmbH is a spin-out of MorphoSys and was founded in March 2018 by Dr. Kathrin Ladetzki-Baehs and Dr. Markus Waldhuber. The headquarter of the company is now in the IZB.<br \/>\n&#8220;Today, therapeutic antibodies are one of the most successful classes of drugs in human medicine. The canine adivo antibody library represents a great and innovative approach that addresses the exciting field of veterinary medicine with products based on the MorphoSys human antibody generation concept,&#8221; commented Dr. Markus Enzelberger, Chief Scientific Officer of MorphoSys.<br \/>\nIn August 2018, adivo announced that it had received seed financing from three investors. &#8220;We are very pleased to have gained three strong and reliable partners with the High-Tech Gr\u00fcnderfonds (HTGF), Occident Group AG and MorphoSys AG. They share our vision of driving innovation in veterinary medicine,&#8221; said Ladetzki-Baehs, CEO of adivo.[\/vc_column_text][vc_column_text css=&#8221;.vc_custom_1583761043671{background-color: #1e73be !important;}&#8221; el_class=&#8221;redaktionell&#8221;][\/vc_column_text][\/vc_column_inner][\/vc_row_inner]\n\n  <div class=\"gco-sc-company\" data-gco-companty-debug=\"should render logo\">\n    <a  href=\"https:\/\/www.izb-online.de\/en\/companies\/adivo-gmbh\/\" class=\"gco-sc-company__primary-action\">\n              <div class=\"gco-sc-company__logo gco-sc-company__logo--as-bground\" style=\"background-image: url(https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/03\/adivo_Start-Up-im-IZB.jpg)\">\n                  <\/div>\n      \n      <div class=\"gco-sc-company__name\">\n        adivo GmbH      <\/div>\n\n      <ul class=\"gco-sc-company__contact\">\n                  <li class=\"gco-sc-company__contact-item gco-sc-company__contact-item--street\">\n            Am Klopferspitz 19          <\/li>\n        \n                  <li class=\"gco-sc-company__contact-item gco-sc-company__contact-item--city\">\n            82152 Planegg\/Martinsried          <\/li>\n        \n        \n        \n              <\/ul>\n    <\/a>\n    <ul class=\"gco-sc-company__contact gco-sc-company__contact--internet\">\n              <li class=\"gco-sc-company__contact-item gco-sc-company__contact-item--website-email\">\n          info@adivo.vet        <\/li>\n      \n              <li class=\"gco-sc-company__contact-item gco-sc-company__contact-item--website-link\">\n          <a href=\"\/\/www.adivo.vet\">\n            www.adivo.vet          <\/a>\n        <\/li>\n          <\/ul>\n  <\/div>\n[\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p><span class=\"gco-utils-excerpt\" data-debug-trim-excerpt=\"423\"><span class=\"gco-utils-excerpt__part-xs\">The biotech start-up adivo has set itself the goal of meeting the high demand for novel<\/span><span class=\"gco-utils-excerpt__part-xl\"> drugs for the treatment of cancer and chronic inflammatory diseases in<\/span><\/span><\/p>\n","protected":false},"author":1,"featured_media":7495,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[286],"tags":[],"class_list":["post-7499","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-izb-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.1 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>adivo develops new drugs for veterinary medicine - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.izb-online.de\/en\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"adivo develops new drugs for veterinary medicine\" \/>\n<meta property=\"og:description\" content=\"The biotech start-up adivo has set itself the goal of meeting the high demand for novel drugs for the treatment of cancer and chronic inflammatory diseases in dogs, with the potential to expand these activities to other animal species in the future. adivo GmbH is a spin-out of MorphoSys and was founded in March 2018 by Dr. Kathrin Ladetzki-Baehs and Dr. Markus Waldhuber. The headquarter of the company is now in the IZB.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.izb-online.de\/en\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\/\" \/>\n<meta property=\"og:site_name\" content=\"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\" \/>\n<meta property=\"article:published_time\" content=\"2018-12-20T12:25:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-07-03T07:37:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/04\/00-Beitragsbild-3.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"400\" \/>\n\t<meta property=\"og:image:height\" content=\"255\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"p534396\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"p534396\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\\\/\"},\"author\":{\"name\":\"p534396\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/person\\\/12499d818c4e3f59388b94103f0a527e\"},\"headline\":\"adivo develops new drugs for veterinary medicine\",\"datePublished\":\"2018-12-20T12:25:34+00:00\",\"dateModified\":\"2020-07-03T07:37:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\\\/\"},\"wordCount\":353,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/00-Beitragsbild-3.jpg\",\"articleSection\":[\"IZB News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.izb-online.de\\\/en\\\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\\\/\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\\\/\",\"name\":\"adivo develops new drugs for veterinary medicine - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/00-Beitragsbild-3.jpg\",\"datePublished\":\"2018-12-20T12:25:34+00:00\",\"dateModified\":\"2020-07-03T07:37:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.izb-online.de\\\/en\\\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/00-Beitragsbild-3.jpg\",\"contentUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/00-Beitragsbild-3.jpg\",\"width\":400,\"height\":255},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IZB Biotech News\",\"item\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/izb-biotech-news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"IZB News\",\"item\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/izb-biotech-news\\\/izb-news\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"adivo develops new drugs for veterinary medicine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\",\"name\":\"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\",\"description\":\"Innovations- und Gr\u00fcnderzentrum Biotechnologie\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#organization\",\"name\":\"F\u00f6rdergesellschaft IZB mbH\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/izb-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/izb-logo.svg\",\"width\":1,\"height\":1,\"caption\":\"F\u00f6rdergesellschaft IZB mbH\"},\"image\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/person\\\/12499d818c4e3f59388b94103f0a527e\",\"name\":\"p534396\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"adivo develops new drugs for veterinary medicine - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.izb-online.de\/en\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\/","og_locale":"en_US","og_type":"article","og_title":"adivo develops new drugs for veterinary medicine","og_description":"The biotech start-up adivo has set itself the goal of meeting the high demand for novel drugs for the treatment of cancer and chronic inflammatory diseases in dogs, with the potential to expand these activities to other animal species in the future. adivo GmbH is a spin-out of MorphoSys and was founded in March 2018 by Dr. Kathrin Ladetzki-Baehs and Dr. Markus Waldhuber. The headquarter of the company is now in the IZB.","og_url":"https:\/\/www.izb-online.de\/en\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\/","og_site_name":"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","article_published_time":"2018-12-20T12:25:34+00:00","article_modified_time":"2020-07-03T07:37:17+00:00","og_image":[{"width":400,"height":255,"url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/04\/00-Beitragsbild-3.jpg","type":"image\/jpeg"}],"author":"p534396","twitter_card":"summary_large_image","twitter_misc":{"Written by":"p534396","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.izb-online.de\/en\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\/#article","isPartOf":{"@id":"https:\/\/www.izb-online.de\/en\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\/"},"author":{"name":"p534396","@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/person\/12499d818c4e3f59388b94103f0a527e"},"headline":"adivo develops new drugs for veterinary medicine","datePublished":"2018-12-20T12:25:34+00:00","dateModified":"2020-07-03T07:37:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.izb-online.de\/en\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\/"},"wordCount":353,"commentCount":0,"publisher":{"@id":"https:\/\/www.izb-online.de\/en\/#organization"},"image":{"@id":"https:\/\/www.izb-online.de\/en\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\/#primaryimage"},"thumbnailUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/04\/00-Beitragsbild-3.jpg","articleSection":["IZB News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.izb-online.de\/en\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.izb-online.de\/en\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\/","url":"https:\/\/www.izb-online.de\/en\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\/","name":"adivo develops new drugs for veterinary medicine - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","isPartOf":{"@id":"https:\/\/www.izb-online.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.izb-online.de\/en\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\/#primaryimage"},"image":{"@id":"https:\/\/www.izb-online.de\/en\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\/#primaryimage"},"thumbnailUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/04\/00-Beitragsbild-3.jpg","datePublished":"2018-12-20T12:25:34+00:00","dateModified":"2020-07-03T07:37:17+00:00","breadcrumb":{"@id":"https:\/\/www.izb-online.de\/en\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.izb-online.de\/en\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.izb-online.de\/en\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\/#primaryimage","url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/04\/00-Beitragsbild-3.jpg","contentUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/04\/00-Beitragsbild-3.jpg","width":400,"height":255},{"@type":"BreadcrumbList","@id":"https:\/\/www.izb-online.de\/en\/adivo-entwickelt-neue-medikamente-fuer-die-veterinaermedizin\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.izb-online.de\/en\/"},{"@type":"ListItem","position":2,"name":"IZB Biotech News","item":"https:\/\/www.izb-online.de\/en\/izb-biotech-news\/"},{"@type":"ListItem","position":3,"name":"IZB News","item":"https:\/\/www.izb-online.de\/en\/izb-biotech-news\/izb-news\/"},{"@type":"ListItem","position":4,"name":"adivo develops new drugs for veterinary medicine"}]},{"@type":"WebSite","@id":"https:\/\/www.izb-online.de\/en\/#website","url":"https:\/\/www.izb-online.de\/en\/","name":"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","description":"Innovations- und Gr\u00fcnderzentrum Biotechnologie","publisher":{"@id":"https:\/\/www.izb-online.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.izb-online.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.izb-online.de\/en\/#organization","name":"F\u00f6rdergesellschaft IZB mbH","url":"https:\/\/www.izb-online.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/06\/izb-logo.svg","contentUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/06\/izb-logo.svg","width":1,"height":1,"caption":"F\u00f6rdergesellschaft IZB mbH"},"image":{"@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/person\/12499d818c4e3f59388b94103f0a527e","name":"p534396"}]}},"_links":{"self":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/posts\/7499","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/comments?post=7499"}],"version-history":[{"count":13,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/posts\/7499\/revisions"}],"predecessor-version":[{"id":11641,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/posts\/7499\/revisions\/11641"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/media\/7495"}],"wp:attachment":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/media?parent=7499"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/categories?post=7499"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/tags?post=7499"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}